Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation

Neval E. Wareham,Qiuju Li,Henrik Sengeløv,Caspar da Cunha-Bang,Finn Gustafsson,Carsten Heilmann,Michael Perch,Allan Rasmussen,Søren Schwartz Sørensen,Amanda Mocroft,Jens D. Lundgren

Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation

2019

Neval E. Wareham
Qiuju Li
Henrik Sengeløv
Caspar da Cunha-Bang
Finn Gustafsson
Carsten Heilmann
Michael Perch
Allan Rasmussen
Søren Schwartz Sørensen
Amanda Mocroft
Jens D. Lundgren

Purpose Solid organ (SOT) and allogeneic haematopoietic stem cell (HSCT) transplant recipients have elevated risks of de novo or secondary cancer. We explored risk factors hereof.

Keywords:

Cancer
Inflammation
Stem cell
Secondary cancer
Cancer research
Biology
Immunology
Transplantation
Haematopoiesis
Oncology
Cohort
Incidence (epidemiology)
Population
Internal medicine
Poisson regression
Hematology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations